Clinical trial
Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery
NCT06959121 is registered in ClinicalTrials.gov with Pulse Biosciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery
- Lead sponsor
- Pulse Biosciences, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 23, 2025
- Completion date
- December 31, 2028
- Enrollment
- 135 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ablation, af, atrial fibrillation, maze procedure